BA
Bayer AG
BAYN.DE·XETRALeverkusen DEFounded 1863100,000 employees
Large CappharmaPublicOncologyCardiologyOphthalmology
Platform: Radiopharma
Market Cap
$28B
All Drugs
7
Clinical Trials
10
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (BAYN.DE)
Loading BAYN.DE stock data...
Drug Pipeline (7 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| BAY-3810 | BAY-3810 | Phase 2/3 | 2 | CD123 | PVAngelman | ||
| BAY-6963 | BAY-6963 | Preclinical | 1 | CD3 | Pancreatic CaPBC | ||
| BAY-8160 | BAY-8160 | Phase 1/2 | 1 | KIF18A | GBMSMA | ||
| Talanesiran | BAY-8138 | Preclinical | 1 | PLK4 | Pompe | ||
| Olpazumab | BAY-5217 | Phase 1 | 2 | CFTR | RB | ||
| Miriratamab | BAY-2224 | Phase 2/3 | 2 | GPRC5D | Gastric CaHNSCC | ||
| Bematinib | BAY-6804 | Phase 2 | 1 | KRASG12C | FLMDD |
SEC Filings & Financial Documents
SEC filings are not available for XETRA-listed companies.
Bayer AG trades on XETRA (DE). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (6)